Therapeutic Asset Ratings

13,155 results matching 1 filter

91,564 assets · 7,904 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
MELPHALAN Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma	Center for International Blood and Marrow Transplant Research	P2	B (62)
MELPHALAN Hodgkins Lymphoma	Thomas Jefferson University	P2	B (62)
MELPHALAN Waldenstrom Macroglobulinemia	Roswell Park Cancer Institute	P2	B (62)
Mesna Acute Lymphoblastic Leukemia	Center for International Blood and Marrow Transplant Research	P2	B (62)
Mesna Acute Undifferentiated Leukemia	Ossium Health, Inc.	P2	B (62)
Mesna Hematopoietic And Lymphoid System Neoplasm	Indapta Therapeutics, INC.	P2	B (62)
METHOTREXATE Acute Leukemia Of Ambiguous Lineage	SWOG Cancer Research Network	P2	B (62)
METHOTREXATE Myelodysplastic Syndrome With Excess Blasts-1	Fred Hutchinson Cancer Center	P2	B (62)
METHOTREXATE Paroxysmal Nocturnal Hemoglobinuria	Fred Hutchinson Cancer Center	P2	B (62)
METHOTREXATE Shwachman-Diamond Syndrome	Fred Hutchinson Cancer Center	P2	B (62)
Mitoxantrone Acute Myeloid Leukemia With Multilineage Dysplasia	Institut de Recherches Internationales Servier	P2	B (62)
MOGAMULIZUMAB Sezary Syndrome	Kyowa Kirin Co., Ltd.	P2	B (62)
Mosunetuzumab B-Cell Non-Hodgkin Lymphoma	BeOne Medicines	P2	B (62)
Multi-Epitope Folate Receptor Alpha-Loaded Dendritic Cell Vaccine Fallopian Tube Clear Cell Adenocarcinoma	Mayo Clinic	P2	B (62)
Multi-Epitope Folate Receptor Alpha-Loaded Dendritic Cell Vaccine Fallopian Tube Carcinoma	Mayo Clinic	P2	B (62)
Multi-Epitope Folate Receptor Alpha-Loaded Dendritic Cell Vaccine Ovarian Carcinoma	Mayo Clinic	P2	B (62)
Nivolumab Acral Lentiginous Melanoma	Fred Hutchinson Cancer Center	P2	B (62)
Nivolumab Clear Cell Renal Carcinoma	Exelixis	P2	B (62)
Nivolumab Prostate Carcinoma	National Cancer Institute (NCI)	P2	B (62)
Nivolumab Childhood Malignant Neoplasm	Australian & New Zealand Children's Haematology/Oncology Group	P2	B (62)
Nivolumab Chordoma	Sarcoma Oncology Research Center, LLC	P2	B (62)
Nivolumab Desmoid Tumor	Parabilis Medicines, Inc.	P2	B (62)
Nivolumab Ewing Sarcoma	Children's National Research Institute	P2	B (62)
Nivolumab HIV Infectious Disease	Universita di Verona	P2	B (62)
Nivolumab Malignant Glioma	University of Florida	P2	B (62)

Showing 1226 to 1250 of 13,155 assets

PreviousPage 50 of 527Next